Grandomics
Beijing, CN · 3 known investors
Find your way into Grandomics
Sign up to see every warm intro you have to Grandomics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Grandomics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Grandomics develops third-generation sequencing services and precision genomic medicine solutions for medical diagnostics, plant and animal breeding, and species conservation. The company applies long-read sequencing technology and computational methods to assemble complete genomes and address applications in medicine, crop improvement, and biodiversity protection.
Founders & leadership
Investors · 3
How we know: the company's own site · funding news · Not right? Tell us
How we know: the company's own site · Not right? Tell us
How we know: funding news · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountSeries BJul 2018Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Grandomics do?
- Grandomics develops third-generation sequencing services and precision genomic medicine solutions for medical diagnostics, plant and animal breeding, and species conservation. The company applies long-read sequencing technology and computational methods to assemble complete genomes and address applications in medicine, crop improvement, and biodiversity protection.
- Who are Grandomics's investors?
- Grandomics's investors include Matrix Partners China, Vitalbridge Capital, Marathon Venture Partners.
- Where is Grandomics headquartered?
- Grandomics is headquartered in Beijing, CN.
